See the DrugPatentWatch profile for Albendazole
Albendazole is an anthelmintic medication used to treat a variety of parasitic worm infestations. It is effective against intestinal parasites such as roundworm, hookworm, whipworm, and pinworm, as well as tissue parasites like the larvae of pork tapeworm (cysticercosis) and liver fluke [1]. The drug functions by inhibiting the polymerization of tubulin in parasitic worms, which disrupts their cellular functions and leads to their death [2].
What are the different uses for Albendazole?
Albendazole is primarily prescribed for treating infections caused by nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes) [1]. This includes common conditions like ascariasis (roundworm infection), ancylostomiasis (hookworm infection), enterobiasis (pinworm infection), and trichuriasis (whipworm infection) [1]. Beyond intestinal parasites, it is a crucial treatment for neurocysticercosis, caused by the larval cysts of the pork tapeworm, and hydatid disease, caused by the larval cysts of the dog tapeworm [1]. It is also used for giardiasis and toxocariasis [1].
How does Albendazole work to kill parasites?
The mechanism of action for albendazole involves binding to beta-tubulin, a protein subunit essential for the formation of microtubules within parasite cells [2][3]. By preventing the assembly of these microtubules, albendazole disrupts vital cellular processes such as cell division, intracellular transport, and the maintenance of cell structure. This ultimately leads to the depletion of energy reserves and the death of the parasite [2][3].
What is the global market outlook for Albendazole?
The market for albendazole is influenced by the prevalence of parasitic infections, particularly in developing countries where sanitation and access to clean water can be challenges [4]. Global health initiatives aimed at controlling neglected tropical diseases (NTDs), many of which are treated with albendazole, also play a significant role in market dynamics [4]. While albendazole is an established drug, ongoing research into new parasitic treatments and changes in public health strategies can impact market trends [4].
When does Albendazole patent exclusivity expire?
Albendazole has been available for many decades, and its original patents have long expired. This means that the drug is available as a generic medication, which has contributed to its widespread use and affordability [5]. Information on specific patent expiry dates for older drugs like albendazole can be tracked through resources such as DrugPatentWatch.com [5].
Who are the main manufacturers of Albendazole?
As a generic medication, albendazole is manufactured by numerous pharmaceutical companies worldwide. Major generic drug manufacturers and pharmaceutical firms in various regions produce albendazole formulations for both human and veterinary use [6].
What are the potential side effects of Albendazole?
While generally well-tolerated, albendazole can cause side effects. Common adverse reactions include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea [1]. Other reported side effects can include headache, dizziness, rash, and elevated liver enzymes [1]. In more serious cases, particularly with long-term or high-dose treatment, more significant side effects affecting the liver, bone marrow, or central nervous system have been observed [1].
Are there any alternatives to Albendazole for parasitic infections?
Several alternative anthelmintic drugs exist, depending on the specific type of parasitic infection. For example, praziquantel is often used for tapeworm and fluke infections, while mebendazole and pyrantel pamoate are alternatives for certain intestinal nematode infections [7]. The choice of treatment is guided by the parasite identified and its susceptibility to different medications [7].
How is Albendazole regulated and approved?
Albendazole is approved for use by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [1]. Its approval is based on demonstrated safety and efficacy in clinical trials for treating specific parasitic infections. Like all medications, it undergoes review and monitoring by health authorities to ensure its continued safe use [1].